Not applicableNot Yet RecruitingNCT07777250
What this trial is testing
Targeting ANKRD11 Reverses HBV-Specific CD8+ T Cell Dysfunction and Tolerance
Who this might be right for
Chronic Hepatitis B
Beijing Municipal Administration of Hospitals 40
Showing 2 of 2 results